Posthepatitic Cirrhosis Clinical Trial
Official title:
Fuzheng Huayu Tablets Against Posthepatitic Cirrhosis
The primary purpose of the trial is adopted Fuzheng Huayu tablets against posthepatitic
cirrhosis, and to build a standard evaluation system for efficacy of traditional Chinese
medicine (TCM).
The second purpose is according to the international clinical guideline and the specialty of
TCM to build a standard clinical trial regulation for traditional Chinese medicine.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment